{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:16:35Z","timestamp":1763018195608,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.109975","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T01:44:17Z","timestamp":1591580657000},"page":"109975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?"],"prefix":"10.1016","volume":"144","author":[{"given":"Aliae A.R.","family":"Mohamed-Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim M.E.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed-Eltaher A.A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109975_b0005","unstructured":"Yanan Li Mengdie Wang Yifan Zhou Jiang Chang Ying Xian Ling Mao Candong Hong Shengcai Chen Yong Wang Hailing Wang Man Li Huijuan Jin Bo Hu Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study 10.2139\/ssrn.3550025 https:\/\/www.ssrn.com\/abstract=3550025."},{"key":"10.1016\/j.mehy.2020.109975_b0010","doi-asserted-by":"crossref","unstructured":"Oxcley T, Mocco J, Majidi S. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young, NEJM, April 28, 2020 DOI: 10.1056\/NEJMc2009787).","DOI":"10.1056\/NEJMc2009787"},{"key":"10.1016\/j.mehy.2020.109975_b0015","doi-asserted-by":"crossref","unstructured":"Wichmann D, Sperhake J, L\u00fctgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; [Epub ahead of print 6 May 2020]. doi: https:\/\/doi.org\/10.7326\/M20-2003).","DOI":"10.7326\/L20-1206"},{"key":"10.1016\/j.mehy.2020.109975_b0020","unstructured":"Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications From Clinical Features to Pathological Findings. Circulation 2020;Apr 16:[Epub ahead of print] https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.120.046988."},{"key":"10.1016\/j.mehy.2020.109975_b0025","doi-asserted-by":"crossref","unstructured":"Paul Little Non-steroidal anti-inflammatory drugs and covid-19 m1185 10.1136\/bmj.m1185 http:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m1185.","DOI":"10.1136\/bmj.m1185"},{"key":"10.1016\/j.mehy.2020.109975_b0030","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","article-title":"Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion","volume":"95","author":"Pillinger","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2020.109975_b0035","doi-asserted-by":"crossref","unstructured":"Glatthaar-Saalm\u00fcller, Bernadette et al. \u201cAntiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study.\u201d Influenza and other respiratory viruses vol. 11,1 (2017): 85-92. doi:10.1111\/irv.12421).","DOI":"10.1111\/irv.12421"},{"key":"10.1016\/j.mehy.2020.109975_b0040","doi-asserted-by":"crossref","unstructured":"Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide. Prostaglandins Leukot Essent Fatty Acids. 1996 Dec;55(6):451-7.","DOI":"10.1016\/S0952-3278(96)90130-1"},{"issue":"4","key":"10.1016\/j.mehy.2020.109975_b0045","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1152\/physrev.00038.2015","article-title":"Platelets in pulmonary immune responses and inflammatory lung diseases","volume":"96","author":"Middleton","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2020.109975_b0050","unstructured":"Medicines and Healthcare Products Regulatory Agency, Commission on Human Medicines. Commission on Human Medicines advice on ibuprofen and coronavirus (covid-19) 14 April 2020. www.gov.uk\/government\/news\/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19."},{"key":"10.1016\/j.mehy.2020.109975_b0055","doi-asserted-by":"crossref","unstructured":"Beth Russell Charlotte Moss Anne Rigg Mieke Van Hemelrijck COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? ecancer 14 10.3332\/ecancer.2020.1023 https:\/\/ecancer.org\/en\/journal\/article\/1023-covid-19-and-treatment-with-nsaids-and-corticosteroids-should-we-be-limiting-their-use-in-the-clinical-setting.","DOI":"10.3332\/ecancer.2020.1023"},{"key":"10.1016\/j.mehy.2020.109975_b0060","unstructured":"World Health Organization, Harvard Health: Coronavirus Resource Center."},{"key":"10.1016\/j.mehy.2020.109975_b0065","unstructured":"The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. WHO evidence brief, 19 April 2020. WHO\/2019-nCoV\/Sci_Brief\/NSAIDs\/2020.1."},{"key":"10.1016\/j.mehy.2020.109975_b0070","unstructured":"Cai Yue, Protective Effect of Aspirin on COVID-19 Patients (PEAC)NCT04365309."},{"key":"10.1016\/j.mehy.2020.109975_b0075","unstructured":"(Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications From Clinical Features to Pathological Findings. Circulation 2020;Apr 16:[Epub ahead of print] https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.120.046988."},{"key":"10.1016\/j.mehy.2020.109975_b0080","unstructured":"Little P. Non-steroidal anti-inflammatory drugs and covid-19. Bmj__)."},{"key":"10.1016\/j.mehy.2020.109975_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/uog.22049","article-title":"Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic","author":"Kwiatkowski Kwiatkowski","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.mehy.2020.109975_b0090","unstructured":"Eva N Hamuly\u00e1k Luuk JJ Scheres Mauritia C Marijnen Mari\u00ebtte Goddijn Saskia Middeldorp Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss 10.1002\/14651858 10.1002\/14651858.CD012852.pub2 http:\/\/doi.wiley.com\/10.1002\/14651858 http:\/\/doi.wiley.com\/10.1002\/14651858.CD012852.pub2."},{"key":"10.1016\/j.mehy.2020.109975_b0095","doi-asserted-by":"crossref","unstructured":"V.G. Jones M. Mills D. Suarez C.A. Hogan D. Yeh J.B. Segal et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hospital Pediatrics. May 1 2020 hpeds-2020.","DOI":"10.1542\/hpeds.2020-0123"},{"key":"10.1016\/j.mehy.2020.109975_b0100","doi-asserted-by":"crossref","unstructured":"N. Tang D. Li X. Wang Z. Sun Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Journal of thrombosis and haemostasis : JTH. 2020 844\u20137.).","DOI":"10.1111\/jth.14768"},{"key":"10.1016\/j.mehy.2020.109975_b0105","article-title":"Acute pulmonary embolism in COVID-19 patients on CT angiography and relationship to D-Dimer levels","volume":"201561","author":"Leonard-Lorant","year":"2020","journal-title":"Radiology"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720312408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720312408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:14Z","timestamp":1759692134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720312408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":21,"alternative-id":["S0306987720312408"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109975","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109975"}}